TLSA
TLSA
NASDAQ · Biotechnology

Tiziana Life Sciences Ltd

$1.50
-0.06 (-3.85%)
As of May 16, 2:08 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,429.3% upside
Low Target $25.58
Average Target $37.94
High Target $45.71
Current Price $1.50
Current
$1.50
Target
$37.94
$25.58 $37.94 avg $45.71
Scenario Analysis
Bear Case
$25.58
1,605.3%
Low target
Base Case
$37.94
+2,429.3%
Avg target
Bull Case
$45.71
+2,947.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.60
-42.3% from high
52-Week Low
$1.14
+31.6% from low
Target vs 52W High
$37.94
+1,359.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%